Compare CXDO & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | STXS |
|---|---|---|
| Founded | 1995 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 210.0M |
| IPO Year | 1998 | 2004 |
| Metric | CXDO | STXS |
|---|---|---|
| Price | $7.45 | $2.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $9.13 | $4.00 |
| AVG Volume (30 Days) | 115.0K | ★ 592.7K |
| Earning Date | 03-03-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 201.70 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $66,346,000.00 | $30,075,000.00 |
| Revenue This Year | $14.40 | $24.21 |
| Revenue Next Year | $11.52 | $29.83 |
| P/E Ratio | $51.97 | ★ N/A |
| Revenue Growth | 12.91 | ★ 19.62 |
| 52 Week Low | $3.75 | $1.54 |
| 52 Week High | $7.65 | $3.59 |
| Indicator | CXDO | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 61.70 |
| Support Level | $6.90 | $2.59 |
| Resistance Level | $7.49 | $2.86 |
| Average True Range (ATR) | 0.28 | 0.13 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 77.54 | 78.81 |
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.